Floatz logo

Insulin Human

Dry Eye Syndrome

Khyber Teaching HospitalUNKNOWNPhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
89/ 100

Competitive context

5 Active assets in the Dry Eye Syndrome cohort.

Asset / SponsorPhaseRating
Cyclosporin A
Barbara Burgos Blasco
Phase 4BBB
Sodium Hyaluronate
Peking University Third Hospital
Phase 4BB
Azithromycin
University of California, San Francisco
Phase 4BB
Vitamin D
University of Faisalabad
Phase 3BB
Diluent
Instituto de Oftalmología Fundación Conde de Valenciana
Phase 3B
Acthar
Toyos Clinic
Phase 4CCC
17-ALLYL-4,5A-EPOXY-3,14-DIHYDROXYMORPHINAN-6-ONE
Seema Capoor
Phase 1CC
Pluripotent Stem Cell-Derived Mesenchymal Stem Cell Exosome Eye Drops
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 1/2NR

Same molecule, other indications

Insulin Human is also rated in:

hyperinsulinismActive
CC
Indicative · Phase 1
44 / 100
View asset →
prediabetes syndromeActive
CC
Indicative · Phase 1
44 / 100
View asset →
metabolic dysfunction-associated steatotic liver diseaseActive
CC
Indicative · Phase 1
42 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →